GlassScriptPhysician profile
Cecily Anto
NPI 1881745602
$10,964.37
in general payments reported to CMS, 2019-2025
50 companies · $1,815 in 2025
The $1,815 reported for 2025 was more than what a typical Clinical Neurophysiology provider received nationally (typical 2025 total: $435).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,636 · 2020: $525 · 2021: $1,409 · 2022: $1,818 · 2023: $1,737 · 2024: $2,024 · 2025: $1,815.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,576.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,575.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,537.64 | 2021-2025 | Botox, Ubrelvy, Qulipta |
| Ucb, INC. | $890.88 | 2019-2024 | Briviact, Rystiggo |
| Biogen, INC. | $699.45 | 2019-2025 | Vumerity, Tysabri, Plegridy |
| Lundbeck LLC | $570.91 | 2020-2025 | Vyepti, Rexulti |
| Pfizer INC. | $569.82 | 2021-2025 | |
| Allergan, INC. | $549.00 | 2019-2022 | |
| Teva Pharmaceuticals USA, INC. | $441.97 | 2019-2022 | |
| Lilly USA, LLC | $414.07 | 2019-2025 | Kisunla, Emgality, Amyvid |
| Genentech USA, INC. | $344.44 | 2019-2025 | Ocrevus, Ocrevus Zunovo |
| Argenx US, INC. | $328.96 | 2023-2025 | Vyvgart Hytrulo, Vyvgart |
| Scilex Pharmaceuticals INC. | $310.23 | 2019-2025 | Ztlido |
| Genzyme Corporation | $300.35 | 2019-2024 | |
| Neurelis, INC. | $285.17 | 2020-2025 | Valtoco |
| Alexion Pharmaceuticals, INC. | $269.10 | 2019-2024 | Ultomiris |
| Novartis Pharmaceuticals Corporation | $229.90 | 2019-2025 |
Show all 50 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cecily Anto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.